Board Decision on a Capital-Constrained Insurance Expansion
Golden Gate Insurance Plc is a fictional Nigerian general insurer with GWP of NGN 12.4bn and a solvency margin of 132%, below its board-approved 150% floor. At a two-day strategy retreat, the CEO proposes an 18-month expansion into three new states and the acquisition of a brokerage for NGN 1.8bn, 60% payable in cash at completion. The board has nine directors, three of whom represent the founding family; the audit committee includes one retired banker but no insurance specialist. Management's board paper contains no independent valuation, no stress test against a 20% claims spike, and no analysis of the brokerage's client concentrations. The next board meeting is in three weeks. The board chair asks you, as company secretary, to advise on how the board should handle the proposal, what governance safeguards are needed, and whether the expansion should proceed.
1. As company secretary, set out how the board should handle the proposal before its next meeting and what governance safeguards it should require. Explain the reasoning behind each safeguard.
Read the worked answer
Recommendation. The board should not approve the transaction at the next meeting. It should receive a decision-ready pack that includes an independent valuation of the brokerage, a pro forma solvency calculation after the NGN 1.8bn purchase and integration costs, a stress test for a 20% claims spike and reserve deterioration, and analysis of the brokerage's top-10 client and commission concentrations.
Governance reasoning. Directors owe duties of care and independent judgement. The current paper creates information asymmetry: management has had months to shape the proposal, while directors have three weeks and no insurance specialist on the audit committee. The board should form an ad hoc committee of independent directors, with external insurance and valuation advisers, and require the family-connected directors to declare interests and withdraw from voting. The transaction should be separated from the broader expansion so each can be rejected on its own merits. Approval should be conditional, not a single yes or no: satisfactory valuation, solvency headroom above the 150% floor under stress, no material related-party links, and a financing plan that does not rely on asset sales not yet contracted. If the pack is incomplete, defer.
2. Evaluate whether the expansion and acquisition should proceed given the 132% solvency margin. What conditions would make either acceptable?
Read the worked answer
Evaluation. A 132% margin is already 18 percentage points below the board's floor. Paying 60% of NGN 1.8bn in cash, or NGN 1.08bn, would reduce capital and add integration, retention and IT costs. The three-state expansion would also consume capital through branch set-up, regulatory deposits and initial underwriting losses. Neither proposal should proceed on the current evidence. The board cannot judge whether post-deal solvency stays above 150%, let alone under a 20% claims shock.
Conditions. Proceed with the acquisition only if an independent valuation supports a price that leaves pro forma solvency above 150% in base and stress cases; consideration is restructured toward deferred or earn-out payments; the seller gives warranties on client concentration and regulatory status; and the board approves a capital injection or reinsurance plan before completion. Proceed with expansion only on a phased basis: one state, capped capital, stage gates at 6 and 12 months, and exit criteria. If management cannot show the stress-test headroom, reject both and ask for a revised strategy that restores the solvency buffer first.